Why would Trump be OK with forcing Americans to pay more than the rest of the world for their drugs? The answer is simple: ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...

The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.

A safety net health care provider has won a $10.3 million interim arbitration judgment against Eagan-based Prime Therapeutics over price-fixing allegations between the local pharmacy benefits manager ...

Many predict that, among other procurement and regulatory reforms, the new administration will implement policies favoring the award of ...

Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...

Adam Colborn, JD, of AMCP, discusses the complexities of drug pricing and what policymakers must consider in efforts to ...

While the former Biden administration showcased the Inflation Reduction Act as a key victory in the fight over high drug ...

Speaking from the Oval Office, Trump justified the tariffs as a response to what he described as excessive migration, drug ...

According to the survey cited by NCPA, 60.4% of independent pharmacists are considering not stocking one or more of the first ...

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for older adults and people with disabilities.

Now that Novo Nordisk A/S’ blockbuster semaglutide franchise has been selected as one drug for the next round of the CMS price negotiation, the Bagsværd, Denmark-based company is asking a U.S.